(R)-2-Hydroxy-2-phenylethyl 4-methylbenzenesulfonate, 95.0%, 5g

N-acetil-D-manosamina, mínimo 98 %, 250 mg, envase de vidrio

Olmutinib, 90%, 1g

1-Hexyl-2,3-dimethyl-1H-imidazol-3-ium chloride, 98%, 500g

1-Propyl-1H-benzoimidazol-2-ylamine, 95.0%, 100mg

tert-butyl 7-amino-2- azaspiro[4.4]nonane-2- carboxylate, 95.0%, 500mg

1-chloro-4-(p-tolyl)phthalazine, 95.0%, 2.5g

2-(3-Bromothiophen-2-yl)acetonitrile, 98%, 250mg

Butyl benzoate, 98.0%, 25ml

2-Cyano-3-(3-chlorophenylethyl)pyridine, 97%, 1g

4-(1-pyrrolidinylmethyl)benzoic acid, 95.0%, 5g

8-Cyclopentyl-5-methyl-2-[[(5-piperazin-1-ylpyridin-2-yl)]amino]-8H-pyrido[2,3-d]pyrimidin-7-one, 97%, 50mg

1-Trifluoromethyl-cyclobutylamine, 98.0%, 1g